FDAFDA · Food and drugs·Recall number D-0165-2023
Rifampin Capsules USP, 300 mg, 100 Capsules (10 x 10) per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC 60687-586-01 (Individual Dose NDC: 60687-586-11)
Published January 25, 2023 · Recall initiated: December 20, 2022
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradations Specifications
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- RIFAMPIN
- Manufacturer
- Amerisource Health Services LLC
- Distributor
- Nationwide in the USA.
- Lot
- Lot #: 1007805, exp. 12/31/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.